Question 26

The most appropriate next step is to quarantine it at the pharmacy.

Quarantining the suspected illegitimate shipment of insulin degludec at the pharmacy is essential to prevent potential harm and ensure compliance with safety regulations.

A) return it to the original source.

Returning the shipment to the original source may not be the best immediate action, as it could allow the shipment to re-enter the supply chain without proper verification and investigation. The safety of patients could be compromised if the product is not first quarantined and assessed.

B) return it to the previous supplier.

Similar to returning it to the original source, returning the shipment to the previous supplier does not address the immediate need to assess the legitimacy of the product. Without quarantining, there remains a risk of further distribution of potentially unsafe medication.

C) quarantine it at the pharmacy.

Quarantining the shipment is the most responsible action as it isolates the product until its legitimacy can be confirmed. This step is crucial to protect patient safety and comply with the provisions of the Drug Supply Chain Security Act (DSCSA).

D) dispose of it at the pharmacy.

Disposing of the shipment without proper investigation could lead to unnecessary loss of medication and does not allow for the possibility of verifying the product’s legitimacy. It is important to first quarantine and assess the situation before deciding on disposal.

Conclusion

Quarantining the shipment is the only option that ensures patient safety while allowing for an investigation into the legitimacy of the product. Other options either risk further distribution of potentially harmful medication or prematurely discard the shipment without proper evaluation. Thus, option C is the most appropriate action in accordance with the Drug Supply Chain Security Act.